<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="9749">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 09, 2023</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05691101</url>
  </required_header>
  <id_info>
    <org_study_id>B-2210/789-001</org_study_id>
    <nct_id>NCT05691101</nct_id>
  </id_info>
  <brief_title>Comparison of Using CIBPB With or Without IV-PCA After Arthroscopic Rotator Cuff Repair</brief_title>
  <official_title>Comparison of Quality of Recovery in Patients Using Continuous Brachial Plexus Block With or Without Intravenous Patient-Controlled Analgesia After Arthroscopic Rotator Cuff Repair: A Prospective Randomized Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Seoul National University Bundang Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Seoul National University Bundang Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The goal of this study is to compare the continuous brachial plexus block with or without&#xD;
      intravenous patient controlled analgesia(PCA) in patients undergoing arthroscopic rotator&#xD;
      cuff repair, in terms of quality of recovery, postoperative pain score, and adverse event.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The Bellomic® M silicone balloon infuser, dual continuous petite type (cebika, Uiwang-si,&#xD;
      Gyeonggi-do, Republic of Korea) has 2-channel infusion elastomeric pump with two balloon&#xD;
      chambers.&#xD;
&#xD;
      This structure allows the simultaneous use of continuous nerve block and intravenous PCA. In&#xD;
      addition, intravenous PCA can be continued even when continuous nerve block is discontinued&#xD;
      due to discomfort such as numbness, tingling sense or motor block.&#xD;
&#xD;
      This is expected to contribute to the patient satisfaction and quality of recovery.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">January 31, 2023</start_date>
  <completion_date type="Anticipated">December 31, 2023</completion_date>
  <primary_completion_date type="Anticipated">December 31, 2023</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Supportive Care</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Korean version of the Quality of Recovery-15 questionnaire (QoR-15K) score (0-150, 0: poor recovery, 150: good recovery)</measure>
    <time_frame>Postoperative 24 hour</time_frame>
    <description>Patient recovery measured by QoR-15K score</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Pain score</measure>
    <time_frame>Postoperative 6, 24, 48 hour</time_frame>
    <description>Numerical Rating Scale (NRS-11(0-10): 0:no Pain and 10:Severe/Worst Pain)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Cumulative consumption of PCA and rescue analgesics</measure>
    <time_frame>Postoperative 24, 48 hour</time_frame>
    <description>Cumulative consumption of systemic analgesics</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Occurrence of adverse effects</measure>
    <time_frame>Postoperative 24, 48 hour</time_frame>
    <description>Nausea, vomiting, numbness, tingling sense, motor and sensory blockade</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">80</enrollment>
  <condition>Analgesia, Patient-Controlled</condition>
  <condition>Brachial Plexus Block</condition>
  <condition>Arthroscopic Rotator Cuff Repair</condition>
  <arm_group>
    <arm_group_label>Continuous interscalene brachial plexus block(CISB) with IV PCA group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Patients in this group received continuous interscalene brachial plexus block(CISB) and intravenous PCA</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Continuous interscalene brachial plexus block (CISB) group</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Patients in this group received continuous interscalene brachial plexus block (CISB)</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>CISB with IV PCA group</intervention_name>
    <description>Ultrasonography guided interscalene brachial plexus block was done with a 5 cm block needle and catheter was inserted. (Stimuplex®A, B Braun Medical, Bethlehem, PA). 10 mL 0.375 % ropivacaine was injected through the catheter.&#xD;
0.2 % ropivacaine 4 ml/hour was injected through the continuous brachial plexus block catheter. IV-PCA with fentanyl (basal flow 0 ml with patient selected bolus 14 mcg, lockout 10 minutes) was started.</description>
    <arm_group_label>Continuous interscalene brachial plexus block(CISB) with IV PCA group</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>CISB group</intervention_name>
    <description>Ultrasonography guided interscalene brachial plexus block was done with a 5 cm block needle and catheter was inserted. (Stimuplex®A, B Braun Medical, Bethlehem, PA). 10 mL 0.375 % ropivacaine was injected through the catheter.&#xD;
0.2 % ropivacaine (4 ml/hour with patient selected bolus 5 ml, lockout 60 minutes) was injected through the continuous brachial plexus block catheter.</description>
    <arm_group_label>Continuous interscalene brachial plexus block (CISB) group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Having arthroscopic rotator cuff repair&#xD;
&#xD;
          -  American Society of Anesthesiologists physical status I-III&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Contraindication to interscalene brachial plexus block&#xD;
&#xD;
          -  Contraindication to fentanyl&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>69 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>JI IN PARK</last_name>
    <role>Principal Investigator</role>
    <affiliation>Seoul National University Bundang Hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>JI IN PARK</last_name>
    <phone>82 10 3077 3666</phone>
    <email>monica0120120@gmail.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Seoul national univercity Bundang Hospital</name>
      <address>
        <city>Seongnam-si</city>
        <state>Gyeonggi-do</state>
        <zip>13620</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ji In Park</last_name>
      <email>monica0120120@gmail.com</email>
    </contact>
  </location>
  <location_countries>
    <country>Korea, Republic of</country>
  </location_countries>
  <verification_date>January 2023</verification_date>
  <study_first_submitted>January 10, 2023</study_first_submitted>
  <study_first_submitted_qc>January 10, 2023</study_first_submitted_qc>
  <study_first_posted type="Actual">January 19, 2023</study_first_posted>
  <last_update_submitted>January 31, 2023</last_update_submitted>
  <last_update_submitted_qc>January 31, 2023</last_update_submitted_qc>
  <last_update_posted type="Actual">February 2, 2023</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Seoul National University Bundang Hospital</investigator_affiliation>
    <investigator_full_name>Ji In Park</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <keyword>Postoperative pain</keyword>
  <keyword>IV PCA</keyword>
  <keyword>Continuous interscalene brachial plexus block</keyword>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

